Therapeutic plasma exchange in critically ill children: A single center experience

Abstract Introduction Therapeutic plasma exchange (TPE) is used in a wide spectrum of diseases in critically ill pediatric patients. We aim to review the indications, complications, safety, and outcomes of critically ill children who received TPE. Methods All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 19 years (January 2013–January 2023) were evaluated retrospectively. A total of 154 patients underwent 486 TPE sessions. Results Median age was 6 years (2–12.5) and 35 children had a body weight of <10 kg (22.7%). Number of organ failure was 4 (2–6). Liver diseases were the most common indication for TPE (31.2%) followed by sepsis with multiorgan dysfunction syndrome (27.3%). Overall survival rate was 72.7%. The highest mortality was observed in hemophagocytic lymphohistiocytosis group. Non‐survivors had significantly higher number of organ failure ( p < 0.001), higher PRISM score ( p < 0.001), and higher PELOD score on admission ( p < 0.001). Adverse events were observed in 68 (13.9%) sessions. Hypotension (7.8%) and hypocalcemia (5.1%) were the most frequent adverse events. Conclusion TPE is safe for critically ill pediatric patients with experienced staff. Survival rate may vary depending on the underlying disease. Survival decreases with the increase in the number of failed organs.